ATE408398T1 - Nanopartikele für dna verabreichung zu einem zielorgan - Google Patents

Nanopartikele für dna verabreichung zu einem zielorgan

Info

Publication number
ATE408398T1
ATE408398T1 AT02767270T AT02767270T ATE408398T1 AT E408398 T1 ATE408398 T1 AT E408398T1 AT 02767270 T AT02767270 T AT 02767270T AT 02767270 T AT02767270 T AT 02767270T AT E408398 T1 ATE408398 T1 AT E408398T1
Authority
AT
Austria
Prior art keywords
nanoparticles
target organ
dna administration
dna
administration
Prior art date
Application number
AT02767270T
Other languages
English (en)
Inventor
Bernhard A Sabel
Christian Walz
Kerstin Ringe
Original Assignee
Nanodel Technologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanodel Technologies Gmbh filed Critical Nanodel Technologies Gmbh
Application granted granted Critical
Publication of ATE408398T1 publication Critical patent/ATE408398T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02767270T 2002-07-29 2002-07-29 Nanopartikele für dna verabreichung zu einem zielorgan ATE408398T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/008434 WO2004017945A1 (en) 2002-07-29 2002-07-29 Nanoparticles for dna administration to a target organ

Publications (1)

Publication Number Publication Date
ATE408398T1 true ATE408398T1 (de) 2008-10-15

Family

ID=31896790

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02767270T ATE408398T1 (de) 2002-07-29 2002-07-29 Nanopartikele für dna verabreichung zu einem zielorgan

Country Status (10)

Country Link
US (1) US7402573B2 (de)
EP (1) EP1526840B1 (de)
JP (1) JP2006500015A (de)
AT (1) ATE408398T1 (de)
AU (1) AU2002331356A1 (de)
CA (1) CA2492807A1 (de)
DE (1) DE60229003D1 (de)
DK (1) DK1526840T3 (de)
ES (1) ES2314097T3 (de)
WO (1) WO2004017945A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314097T3 (es) 2002-07-29 2009-03-16 Nanodel Technologies Gmbh Nanoparticulas para la administracion de adn a un organo diana.
PL1796650T3 (pl) * 2004-09-14 2009-06-30 Nanodel Tech Gmbh Nanocząstki zawierające dostarczające podłoże
EP1661559A1 (de) * 2004-11-25 2006-05-31 NanoDel Technologies GmbH Verabreichungssystem hergestellt durch ein Miniemulsionsverfahren
WO2006056362A2 (en) * 2004-11-25 2006-06-01 Nanodel Technologies Gmbh Delivery vehicle manufactured by the miniemulsion method
WO2006130943A1 (en) * 2005-06-10 2006-12-14 The Governors Of The University Of Alberta Respirable dried powder formulation comprising drug loaded nanoparticles
EP1815851A1 (de) * 2006-02-03 2007-08-08 NanoDel Technologies GmbH Nanopartikel zur Arzneistoffverabreichung
EP2029119A2 (de) * 2006-06-08 2009-03-04 Bayer Schering Pharma Aktiengesellschaft Funktionalisierte, feste polymernanopartikel für diagnostische und therapeutische anwendungen
JP4963221B2 (ja) * 2006-11-24 2012-06-27 公立大学法人横浜市立大学 シアノアクリレート系ポリマー粒子及びその製造方法
JP5224313B2 (ja) * 2007-02-27 2013-07-03 公立大学法人横浜市立大学 プラスミド送達用粒子
RU2617059C2 (ru) * 2014-11-11 2017-04-19 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Способ получения амфифильных блок-сополимеров N,N-диметиламиноэтилметакрилата для доставки нуклеиновых кислот в живые клетки
JP2020517638A (ja) 2017-04-20 2020-06-18 エータイアー ファーマ， インコーポレイテッド 肺の炎症を治療するための組成物および方法
DK3615023T3 (da) 2017-04-25 2023-09-25 Ischemix Llc Lipoyl-glu-ala til behandlingen af neurodegenerativ skade forårsaget af traumatisk hjerneskade
CN118063599A (zh) 2018-07-03 2024-05-24 吉利德科学公司 靶向hiv gp120的抗体和使用方法
CR20210687A (es) 2019-06-25 2022-03-03 Gilead Sciences Inc PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO
CN114761041A (zh) 2019-07-16 2022-07-15 吉利德科学公司 Hiv疫苗及其制备和使用方法
KR20220074917A (ko) 2019-09-30 2022-06-03 길리애드 사이언시즈, 인코포레이티드 Hbv 백신 및 hbv를 치료하는 방법
CA3128035A1 (en) 2020-08-13 2022-02-13 Bioasis Technologies, Inc. Combination therapies for delivery across the blood brain barrier
TWI815194B (zh) 2020-10-22 2023-09-11 美商基利科學股份有限公司 介白素2-Fc融合蛋白及使用方法
WO2024015741A1 (en) 2022-07-12 2024-01-18 Gilead Sciences, Inc. Hiv immunogenic polypeptides and vaccines and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184242C (en) * 1994-02-28 2000-05-02 Jorg Kreuter Drug targeting system, method for preparing same and its use
US6248720B1 (en) * 1996-07-03 2001-06-19 Brown University Research Foundation Method for gene therapy using nucleic acid loaded polymeric microparticles
WO1997003702A1 (en) * 1995-07-21 1997-02-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles
CA2295177C (en) * 1997-06-13 2007-01-09 Medinova Medical Consulting Gmbh Drug targeting system, method of its preparation and its use
US6265546B1 (en) * 1997-12-22 2001-07-24 Genset Prostate cancer gene
JP2003501379A (ja) * 1999-06-02 2003-01-14 ナノファーマ アーゲー ガン治療のための薬剤を充填したナノパーティクルの使用
ES2314097T3 (es) 2002-07-29 2009-03-16 Nanodel Technologies Gmbh Nanoparticulas para la administracion de adn a un organo diana.

Also Published As

Publication number Publication date
WO2004017945A1 (en) 2004-03-04
ES2314097T3 (es) 2009-03-16
CA2492807A1 (en) 2004-03-04
EP1526840B1 (de) 2008-09-17
DE60229003D1 (de) 2008-10-30
US20050175710A1 (en) 2005-08-11
DK1526840T3 (da) 2008-11-03
JP2006500015A (ja) 2006-01-05
EP1526840A1 (de) 2005-05-04
US7402573B2 (en) 2008-07-22
AU2002331356A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
ATE408398T1 (de) Nanopartikele für dna verabreichung zu einem zielorgan
EP2172549A3 (de) Rnai expressionskonstrukte
RS51213B (sr) Farmaceutski vaginalni gel koji sadrži tenofovir
CY1115525T1 (el) Συνθεση και χρηση αντι-αντιστροφων φωσφοροθειοϊκων αναλογων της καλυπτρας αγγελιοφορου rna
MX2007005200A (es) Plaquetas a partir de celulas germinales.
TR201909609T4 (tr) Modifiye edilmiş nükleosidleri içeren rna ve kullanım yöntemleri.
EP2029754A4 (de) Magnetosomen-genexpression in eukaryontischen zellen
WO2007055905A3 (en) Compositions and methods of vascular injury repair
EP2732819A3 (de) Verbindungen zur Verstärkung der ATOH-1-Expression
EP2446862A3 (de) Amphiphile Peptide und Hydrogelmatrizen daraus zur Knochenreparatur
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
EP2366787A3 (de) Codonoptimierte IL-15- und IL-15R-Alpha-Gene zur Expression von Säugetierzellen
GB2472964A (en) Vectors for delivery of light-sensitive proteins and methods of use
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
NZ592688A (en) Modified blood factors comprising a low degree of water soluble polymer
EP1987165A4 (de) Gene mit einfluss auf die menschliche gedächtnisleistung
WO2004094610A3 (en) Wnt as a factor for cardiac myogenesis
NO20070780L (no) Celloverflateprotein.
WO2006128885A3 (en) Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation
WO2004099364A3 (en) Multicellular compositions of pluripotent human embryonic stem cells and cancer cells
CA2441535A1 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
WO2006042005A3 (en) Global gene expression profiling of circulating tumor cells
ATE239749T1 (de) Phosphor-enthaltende dendrimere als transfektionsagente
NO20063715L (no) Syntese av spongosin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee